Your browser doesn't support javascript.
loading
Onward transmission of measles virus among vaccinated cases in a large community outbreak in Auckland, New Zealand, 2019.
Evans, Imogen; Jury, Sheryl; Morrison, Anne; Best, Emma; King, Victoria; Reynolds, Edwin.
Afiliación
  • Evans I; Auckland Regional Public Health Service, Health New Zealand - Te Whatu Ora Te Toka Tumai Auckland, New Zealand. Electronic address: imogen.evans.ie@gmail.com.
  • Jury S; Auckland Regional Public Health Service, Health New Zealand - Te Whatu Ora Te Toka Tumai Auckland, New Zealand.
  • Morrison A; Auckland Regional Public Health Service, Health New Zealand - Te Whatu Ora Te Toka Tumai Auckland, New Zealand.
  • Best E; Department of Paediatrics: Child and Youth Health, The University of Auckland, New Zealand.
  • King V; Department of Paediatrics: Child and Youth Health, The University of Auckland, New Zealand.
  • Reynolds E; Auckland Regional Public Health Service, Health New Zealand - Te Whatu Ora Te Toka Tumai Auckland, New Zealand.
Vaccine ; 42(23): 126257, 2024 Oct 03.
Article en En | MEDLINE | ID: mdl-39191179
ABSTRACT

BACKGROUND:

Isolation of cases and quarantining of non-immune contacts are the mainstay of measles outbreak management in elimination settings. Serology testing of exposed contacts may not be feasible in large outbreaks; therefore, vaccination history is used as a proxy for determining immunity to measles and thus prevention of onward virus transmission. This study sought to investigate the risk of measles virus transmission from individuals with a history of one or two doses of measles-containing vaccine (MCV).

METHODS:

 Retrospective analysis of data from measles cases reported to Auckland Regional Public Health Service during the 2019 Auckland region measles outbreak. Vaccination history was verified using patient records and the New Zealand National Immunisation Register. Onward transmission was determined through case interviews and assessment of exposed contacts.

RESULTS:

 1451 measles cases were assessed as eligible for vaccination at the time of measles outbreak. Of these, 1015 (70.0%) were unvaccinated, 220 (15.2%) had unknown vaccination status, 139 (9.6%) had received only one dose of MCV and 77 (5.3%) had received two doses of the vaccine. Compared to unvaccinated cases, the odds of onward transmission were lower among those with one dose only (OR 0.41, 95% CI 0.20-0.75) or two doses of MCV (OR 0.44, 95% CI 0.17-0.95). Median time since vaccination was longer among those with onward transmission compared to those without onward transmission for one and two doses of the vaccine, suggesting a potential effect of waning immunity among this cohort.

CONCLUSION:

 These findings support the hypothesis that measles cases with a history of prior vaccination are less likely to transmit the virus to others compared to unvaccinated cases. Such information can be used to support decisions around quarantine requirements for vaccinated contacts in future measles outbreaks.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacuna Antisarampión / Brotes de Enfermedades / Vacunación / Sarampión / Virus del Sarampión Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged País/Región como asunto: Oceania Idioma: En Revista: Vaccine Año: 2024 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacuna Antisarampión / Brotes de Enfermedades / Vacunación / Sarampión / Virus del Sarampión Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged País/Región como asunto: Oceania Idioma: En Revista: Vaccine Año: 2024 Tipo del documento: Article Pais de publicación: Países Bajos